You are here: Industry Insights > Announces

News List

GVK BIO announces new appointment biospectrumasia
September 06, 2019
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as the New Chief Commercial Officer of GVK BIO
Compugen Announces Board of Directors Appointment americanpharmaceuticalreview
July 03, 2019
Compugen announced the appointment of Eran Perry to its board of directors, effective July 1, 2019. In addition, the Company announced that Yair Aharonowitz, Ph.D. and Arie Ovadia, Ph.D. will retire from its board of directors and will not be brought for
Ionis Announces Board of Directors Appointment americanpharmaceuticalreview
June 14, 2019
Ionis Pharmaceuticals announced the appointment of a new member to its board of directors effective immediately – Joan E. Herman, MBA, MS, president and chief executive officer of Herman and Associates.
CutisPharma Announces Acquisition of Silvergate Pharmaceuticals americanpharmaceuticalreview
June 13, 2019
CutisPharma has announced its acquisition of Silvergate Pharmaceuticals and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals.
Regulus Announces New Additions to Board of Directors firstwordpharma
June 12, 2019
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs……
Rejenevie™ Therapeutics Announces Start of AR-100 Trial americanpharmaceuticalreview
May 30, 2019
Rejenevie™ Therapeutics announced the commencement of the company's Phase II clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy to boost the function of the aging immune system.
Lannett Announces Board of Directors Appointment americanpharmaceuticalreview
May 24, 2019
Lannett announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019. Following the appointment of Dr. Rewolinski, the board will comprise eight directors.
Array BioPharma Announces BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints americanpharmaceuticalreview
May 22, 2019
Array BioPharma announced positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI® (encorafenib), a BRAF inhibitor, MEKTOVI® (binimetinib) ...
Encube Ethicals Announces New Mfg. Facility contractpharma
April 19, 2019
Encube Ethicals has announced that its new high potency manufacturing facility for topical formulations is now fully operational.
Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock firstwordpharma
April 04, 2019
The Company intends to use the net proceeds of both offerings for research and product development activities

Previous page 1 2 Next page